Evidence map›Paper›PMID 30282975›Full record

Trial reportScientific reports2018

Patients with Chronic Obstructive Pulmonary Disease harbour a variation of Haemophilus species.

Karen L Osman, Johanna M C Jefferies, Christopher H Woelk, Nathalie Devos, Thierry G Pascal, Marie-Cécile Mortier, Jeanne-Marie Devaster, Tom M A Wilkinson, David W Cleary, Stuart C Clarke and 1 more

Registry-linked trialAbstract readClinical Trial
In one paragraph

Trial report in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01360398 (Contribution of Infectious Pathogens to Acute Respiratory Illness in Adults and Elderly), which is not on this map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01360398 nacompletednot on this map

Contribution of Infectious Pathogens to Acute Respiratory Illness in Adults and Elderly

TypeinterventionalSponsorGlaxoSmithKlineRan2011 to 2014Enrolled127ConditionsRespiratory DisordersArmsBlood sample, Sputum sample, Nasopharyngeal swab, Urine sample, End tidal breath sample
3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  4. Article
  5. Non-typeableEuropean respiratory review : an official journal of the European Respiratory Society · 2022
    Review
  6. Article
  7. Observational
  8. Article
  9. Article
  10. Review
  11. Learning from -omics strategies applied to uncoverComputational and structural biotechnology journal · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Karen L OsmanClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK.
Johanna M C JefferiesClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK.
Christopher H WoelkClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK.
Nathalie DevosGlaxoSmithKline Pharmaceuticals, Wavre, Belgium.
Thierry G PascalGlaxoSmithKline Pharmaceuticals, Wavre, Belgium.
Marie-Cécile MortierGlaxoSmithKline Pharmaceuticals, Wavre, Belgium.
Jeanne-Marie DevasterGlaxoSmithKline Pharmaceuticals, Wavre, Belgium.
Tom M A WilkinsonClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK.
David W ClearyClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK.
Stuart C ClarkeClinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, Hants, SO16 6YD, UK. S.C.Clarke@soton.ac.uk.
AERIS Study Group

Funding

Wellcome Trust
6 · The paper itself

Abstract

H. haemolyticus is often misidentified as NTHi due to their close phylogenetic relationship. Differentiating between the two is important for correct identification and appropriate treatment of infective organism and to ensure any role of H. haemolyticus in disease is not being overlooked. Speciation however is not completely reliable by culture and PCR methods due to the loss of haemolysis by H. haemolyticus and the heterogeneity of NTHi. Haemophilus isolates from COPD as part of the AERIS study (ClinicalTrials - NCT01360398) were speciated by analysing sequence data for the presence of molecular markers. Further investigation into the genomic relationship was carried out using average nucleotide identity and phylogeny of allelic and genome alignments. Only 6.3% were identified as H. haemolyticus. Multiple in silico methods were able to distinguish H. haemolyticus from NTHi. However, no single gene target was found to be 100% accurate. A group of omp2 negative NTHi were observed to be phylogenetically divergent from H. haemolyticus and remaining NTHi. The presence of an atypical group from a geographically and disease limited set of isolates supports the theory that the heterogeneity of NTHi may provide a genetic continuum between NTHi and H. haemolyticus.

Indexed as

PhylogenyAdultAgedAged, 80 and overFemaleHaemophilus InfectionsHaemophilus influenzaeHumansMaleMiddle AgedPhosphotransferasesPolymerase Chain ReactionPulmonary Disease, Chronic ObstructivePhosphotransferases

Identifiers

PMID30282975
PMCPMC6170463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.